Event Date: 24th May 2023
Event Location: Webinar
Watch NowWith the progress of precision medicine and the development of biopharmaceutical technology, development and investment into gene therapy drugs is increasing. Gene therapy drugs are opening new doors for the treatment of many genetic diseases and are also offering new approaches to the treatment of chronic and infectious diseases. However, since these drugs are relatively new to the market, there are still many technical bottlenecks and clinical trial challenges for us to break through and overcome. For example, how to facilitate the clinical translation of gene therapy technology needs further exploration; in addition, understanding the regulatory process of gene therapy products and how to deal with the regulatory differences between different regions or countries is important to planning a successful trial. Through the discussion of early development, registration and clinical trial management, we can help sponsors to develop a more efficient product development plan, leading to more effective novel treatment options.
Dr. Gao Guang, CMC Head, Executive Director, Caidya
Stand up for innovation. Stand up for truth. And stand up ...
With the progress of advanced precision medicine over rece...
From 2009 to 2023, for more than 14 years, DIA China has b...